Gemcitabine plus S-1 for metastatic pancreatic cancer

To investigate the treatment effects of gemcitabine plus S-1 (GS) for metastatic pancreatic cancer in our institution. Data from 41 patients with metastatic pancreatic cancer treated with GS regimen in West China Hospital, Sichuan University were reviewed. The therapeutic efficacy and toxicity were...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hong, Yi, Cheng, Zhao, Yaqin, Gou, Hongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203537/
https://www.ncbi.nlm.nih.gov/pubmed/30313120
http://dx.doi.org/10.1097/MD.0000000000012836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203537/
https://www.ncbi.nlm.nih.gov/pubmed/30313120
http://dx.doi.org/10.1097/MD.0000000000012836

Ejemplares similares